Dr. Suzie Bash Joins Cortechs.ai Medical Advisory Board

Neuroradiology expert to bring significant clinical expertise, ultimately allowing for better patient care

(SAN DIEGO) November 20, 2019 – Cortechs.ai Inc. is pleased to announce that Dr. Suzie Bash, one of the most highly regarded neuroradiologists in the United States (U.S.), has joined the company’s medical advisory board and will bring significant clinical expertise. Dr. Bash has been an expert user of Cortechs.ai’ volumetric magnetic resonance imaging (MRI) solution, NeuroQuant®, for over 12 years and is an avid supporter of the technology, contributing, as a user, to its development. This formalized relationship will provide a framework for more direct feedback and input to future product
development, allowing Cortechs.ai’ products to more directly address physician needs to provide
better patient care.

“We are extremely happy to welcome Dr. Bash to our medical advisory board,” said Dr. Chris Airriess,
chief executive officer of Cortechs.ai, “As one of the most respected and highly referred to neuroradiologists in the U.S., an early adopter of volumetric imaging and vocal supporter of Cortechs.ai’ suite of AI tools for advanced imaging, she will be a great resource, both internally to employees and externally to the health care providers we partner with.”

Dr. Bash is the medical director of neuroradiology at San Fernando Valley Interventional Radiology, part of the RadNet outpatient imaging network. Prior to joining RadNet in 2005, she was an assistant
professor of neuroradiology at the University of California, Los Angeles (UCLA) subsequent to a two-year neuroradiology fellowship and radiology residency at that institution. During her tenure at UCLA, Dr. Bash was the recipient of the Issa Yaghmai Scholarship for best paper published in a peer-reviewed
journal; Consultant of the Year Award, issued by the emergency department to one UCLA resident a
year; as well as the Outstanding Resident Award, issued by Olive View-UCLA to one resident a year.

“I have had long-standing interest in the potential of AI tools to transform neuroimaging studies into
more accurate, meaningful and clinically useful exams,” said Dr. Bash, “I am excited to be a part of a company that I have directly observed over the past 12 years elevate patient care through the use of
their pioneering volumetric MR post-processing tools.”

Dr. Bash was awarded James Scholar Honors during her medical school years at the University of Illinois. Dr. Bash’s passion and interests lie in artificial intelligence applications in neuroimaging and other advanced neuroimaging techniques which add patient-centric value and quality.

About Cortechs.ai
Cortechs.ai develops and markets breakthrough medical device software solutions capable of
automatically segmenting and quantifying brain structures, making quantitative analysis of the human
brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides
neurologists, radiologists and clinical researchers worldwide with a convenient and cost-effective means to quantify brain structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development abnormalities. Please visit cortechs.ai for further information and follow us on Twitter, LinkedIn and Facebook.

###

Insights

19 December 2024

Elevating Neurological CT Precision and Efficiency

Learn how this powerful tool improves measurement accuracy, clinical confidence, and patient outcomes by streamlining workflows.

19 December 2024

OnQ Prostate: Advancing Prostate Cancer Imaging with OnQ Prostate

Discover how this advanced technology enhances diagnostic accuracy, reduces variability, and supports more informed clinical decisions.

19 December 2024

NeuroQuant Brain Tumor – Advancing Tumor Quantification in Clinical Practice

Discover how NeuroQuant® Brain Tumor can streamline tumor quantification, reduce manual workload, and support more precise decision-making.
Scroll to Top